Pancrelipase

Specification

• Cat#: THP-0039
• Product Name: Pancrelipase
• Cas No: 53608-75-6
• Description: The product, in general, is composed of a mixture of pancreatic enzymes which include amylases, lipases, and proteases. These enzymes are extracted from porcine pancreatic glands.
• Sequences: Not Available
• Species: Porcine
• Molecular Weight: 131000.0 Da
• Formula: Not Available
• Endotoxin: <0.001 EU per 1 μg of the peptide by the LAL method
• Application: The use of the product amylase is part of the pancreatic enzyme replacement therapy. This therapy is indicated for the treatment of pancreatic insufficiency attributed to cystic fibrosis, chronic pancreatitis or any other medically defined pancreatic disease that might require it. Pancreatic diseases are associated with the deterioration of pancreatic parenchyma and of the dual physiological functions of the pancreas. Once established, pancreatic insufficiency results in malnutrition, weight loss, and steatorrhea.

Pharmaceutical Information

• Pharmaceutical Application: Pancrelipase